SPRING VALLEY, N.Y., Feb. 21 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. invites investors and the general public to listen to a webcast of a conference call with investment analysts at 8:00 a.m. EST on Tuesday, February 28. The purpose of the call is to review and discuss fourth-quarter earnings results for the period ended December 31, 2005. Par will issue its earnings announcement earlier that morning.
Access to the live webcast can be made via the company’s website at http://www.parpharm.com. A digital replay of the conference call will be available for 24 hours approximately one hour after the call. The dial-in numbers for the replay is 888-286-8010 for domestic callers and 617-801-6888 for international callers. When prompted, the passcode is 41298868.
Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. In 2005, Par received approval for and introduced Megace(R) ES, its first branded pharmaceutical product, and expects to launch its second in 2006. Par’s Generic Products Division is committed to providing high-quality pharmaceuticals that are affordable and accessible to patients. Par manufactures, markets or licenses more than 100 generic drugs. For press release and other company information, visit http://www.parpharm.com.
Par Pharmaceutical Companies, Inc.
CONTACT: Cecelia C. Heer of Par Pharmaceutical Companies, Inc.,+1-201-802-4000
Web site: http://www.parpharm.com/
